These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1619 related articles for article (PubMed ID: 21575663)

  • 1. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease.
    Larbanoix L; Burtea C; Laurent S; Van Leuven F; Toubeau G; Vander Elst L; Muller RN
    Neurobiol Aging; 2010 Oct; 31(10):1679-89. PubMed ID: 19027991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
    Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
    Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
    Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
    Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
    Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
    Burtea C; Laurent S; Lancelot E; Ballet S; Murariu O; Rousseaux O; Port M; Vander Elst L; Corot C; Muller RN
    Mol Pharm; 2009; 6(6):1903-19. PubMed ID: 19743879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
    André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C
    J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.
    Ziehm T; Brener O; van Groen T; Kadish I; Frenzel D; Tusche M; Kutzsche J; Reiß K; Gremer L; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2016 Aug; 7(8):1088-96. PubMed ID: 27240424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.